A systematic review of validated methods to capture several rare conditions using administrative or claims data

Vaccine

Volumn 31, Issue S10, 2013, Pages

  Lee, Christopher D ^a   Williams, S Elizabeth ^a   Sathe, Nila A ^a   McPheeters, Melissa L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute disseminated encephalomyelitis; Administrative data; Henoch Sch nlein purpura; International Classification of Diseases; Optic neuritis; Tics

Indexed keywords

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ALGORITHM; ANAPHYLACTOID PURPURA; BILLING AND CLAIMS; DISEASE CLASSIFICATION; DRUG EXPOSURE; HEALTH SURVEY; HUMAN; ICD-9; INCIDENCE; INFECTION; MEDLINE; OPTIC NEURITIS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TIC; VACCINATION; VALIDATION PROCESS; VALIDITY;

ACE; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADEM; ADMINISTRATIVE DATA; ANGIOTENSIN CONVERTING ENZYME; FDA; HEALTH MAINTENANCE ORGANIZATION; HENOCH SCHÖNLEIN PURPURA; HMO; HSP; ICD; INTERNATIONAL CLASSIFICATION OF DISEASES; MS; MULTIPLE SCLEROSIS; ON; OPTIC NEURITIS; TCV; THIMEROSAL CONTAINING VACCINES; TICS; US FOOD AND DRUG ADMINISTRATION;

ALGORITHMS; DATABASES, FACTUAL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; EPIDEMIOLOGIC METHODS; HUMANS; INCIDENCE; INSURANCE CLAIM REVIEW; INTERNATIONAL CLASSIFICATION OF DISEASES; OPTIC NEURITIS; PURPURA, SCHOENLEIN-HENOCH; TICS;

EID: 84891908883     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.03.044     Document Type: Review

References (20)

1. Nguyen M., Ball R., Midthun K., Lieu T.A. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Saf 2012, 21(January (Suppl. 1)):291-297.
2. Lieu T.A., Nguyen M.D., Ball R., Martin D.B. Health outcomes of interest for evaluation in the Post-Licensure Rapid Immunization Safety Monitoring Program. Vaccine 2012, 30(April (18)):2824-2830.
3. Alper G. Acute disseminated encephalomyelitis. J Child Neurol 2012, 27(November (11)):1408-1425.
4. El-Dairi MA, Ghasia F, Bhatti MT. Pediatric optic neuritis. Int Ophthalmol Clin 2012 Summer;52(3):29-49, xii.
5. Gal R.L., Vedula S.S., Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev 2012, 4:CD001430.
6. Singer H.S. Tourette syndrome and other tic disorders. Handb Clin Neurol 2011, 100:641-657.
7. Weiss P.F. Pediatric vasculitis. Pediatr Clin North Am 2012, 59(April (2)):407-423.
8. McPheeters M, Sathe N, Jerome R, Carnahan R. Methods for systematic reviews of administrative database studies capturing health outcomes of interest vaccine (in review).
9. Carnahan R.M., Moores K.G. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned. Pharmacoepidemiol Drug Saf 2012, 21(January (Suppl. 1)):82-89.
10. Leake J.A., Albani S., Kao A.S., Senac M.O., Billman G.F., Nespeca M.P., et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 2004, 23(August (8)):756-764.
11. Langer-Gould A., Zhang J.L., Chung J., Yeung Y., Waubant E., Yao J. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology 2011, 77(September (12)):1143-1148.
12. Winthrop K.L., Chen L., Fraunfelder F.W., Ku J.H., Varley C.D., Suhler E., et al. Initiation of anti-TNF therapy and the risk of optic neuritis; from the safety assessment of biologic therapy (SABER) Study. Am J Ophthalmol 2013, 155(January (1)):183-189.
13. Geier D.A., Geier M.R. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis. Med Sci Monit 2005, 11(April (4)):CR160-CR170.
14. Young H.A., Geier D.A., Geier M.R. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci 2008, 271(August (1-2)):110-118.
15. Verstraeten T., Davis R.L., DeStefano F., Lieu T.A., Rhodes P.H., Black S.B., et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 2003, 112(November (5)):1039-1048.
16. Leslie D.L., Kozma L., Martin A., Landeros A., Katsovich L., King R.A., et al. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. J Am Acad Child Adolesc Psychiatry 2008, 47(October (10)):1166-1172.
17. Goodman M.J., Nordin J.D., Belongia E.A., Mullooly J.P., Baggs J. Henoch-Scholein purpura and polysaccharide meningococcal vaccine. Pediatrics 2010, 126(August (2)):e325-e329.
18. El Tallawy H.N., Farghaly W.M., Metwaly N.A., Rageh T.A., Shehata G.A., Elfetoh N.A., et al. Door-to-door survey of major neurological disorders in Al Kharga District, New Valley, Egypt: methodological aspects. Neuroepidemiology 2010, 35(3):185-190.
19. Savettieri G., Salemi G., Rocca W.A., Meneghini F., Santangelo R., Morgante L., et al. Incidence and lifetime prevalence of Bell's palsy in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group. Acta Neurol Scand 1996, 94(July (1)):71-75.
20. Lee C.D., Jones T.F. Hospital discharge database optimization in Guillain-Barre syndrome surveillance. Muscle Nerve 2012, 46(July (1)):60-62.